These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33741228)

  • 81. Molecular genetic study of Calpainopathy in Iran.
    Mojbafan M; Khajeh A; Habibi H; Bagherian H; Zeinali S
    Gene; 2018 Nov; 677():259-265. PubMed ID: 30056071
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Clinical-genetic characteristics of limb girdle-muscular dystrophy type 2A].
    Dadali EL; Shagina OA; Ryzhkova OP; Rudenskaia GE; Fedotov VP; Poliakov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):79-83. PubMed ID: 20517216
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.
    Beckmann JS; Spencer M
    Neuromuscul Disord; 2008 Dec; 18(12):913-21. PubMed ID: 18974005
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Restriction of calpain3 expression to the skeletal muscle prevents cardiac toxicity and corrects pathology in a murine model of limb-girdle muscular dystrophy.
    Roudaut C; Le Roy F; Suel L; Poupiot J; Charton K; Bartoli M; Richard I
    Circulation; 2013 Sep; 128(10):1094-104. PubMed ID: 23908349
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Camptocormia: the bent spine syndrome, an update.
    Lenoir T; Guedj N; Boulu P; Guigui P; Benoist M
    Eur Spine J; 2010 Aug; 19(8):1229-37. PubMed ID: 20300781
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Developing fluorescence sensor probe to capture activated muscle-specific calpain-3 (CAPN3) in living muscle cells.
    Ojima K; Hata S; Shinkai-Ouchi F; Oe M; Muroya S; Sorimachi H; Ono Y
    Biol Open; 2020 Sep; 9(9):. PubMed ID: 32801165
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Limb-girdle muscular dystrophy 2A.
    Gallardo E; Saenz A; Illa I
    Handb Clin Neurol; 2011; 101():97-110. PubMed ID: 21496626
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Radiation-induced camptocormia and dropped head syndrome: Review and case report of radiation-induced movement disorders.
    Seidel C; Kuhnt T; Kortmann RD; Hering K
    Strahlenther Onkol; 2015 Oct; 191(10):765-70. PubMed ID: 26072168
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Camptocormia in a patient with Parkinson disease and a myopathy with nemaline rods.
    Ozer F; Ozturk O; Meral H; Serdaroglu P; Yayla V
    Am J Phys Med Rehabil; 2007 Jan; 86(1):3-6. PubMed ID: 17304682
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Isolated camptocormia revealing sporadic late onset nemaline myopathy.
    Kemta Lekpa F; Chevalier X; Dubourg O; Dimitri D
    Presse Med; 2013; 42(7-8):1142-4. PubMed ID: 23498645
    [No Abstract]   [Full Text] [Related]  

  • 91. Is camptocormia a primary muscular disease?
    Laroche M; Delisle MB; Aziza R; Lagarrigue J; Mazieres B
    Spine (Phila Pa 1976); 1995 May; 20(9):1011-6. PubMed ID: 7631230
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Divergent Features of Mitochondrial Deficiencies in LGMD2A Associated With Novel Calpain-3 Mutations.
    El-Khoury R; Traboulsi S; Hamad T; Lamaa M; Sawaya R; Ahdab-Barmada M
    J Neuropathol Exp Neurol; 2019 Jan; 78(1):88-98. PubMed ID: 30500922
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies.
    Sarparanta J; Blandin G; Charton K; Vihola A; Marchand S; Milic A; Hackman P; Ehler E; Richard I; Udd B
    J Biol Chem; 2010 Sep; 285(39):30304-15. PubMed ID: 20634290
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Is deltoid muscle biopsy useful in isolated camptocormia? A prospective study.
    Chanson JB; Lannes B; Echaniz-Laguna A
    Eur J Neurol; 2016 Jun; 23(6):1086-92. PubMed ID: 26969127
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.
    Lostal W; Roudaut C; Faivre M; Charton K; Suel L; Bourg N; Best H; Smith JE; Gohlke J; Corre G; Li X; Elbeck Z; Knöll R; Deschamps JY; Granzier H; Richard I
    Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776291
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
    Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
    Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease.
    Wrede A; Margraf NG; Goebel HH; Deuschl G; Schulz-Schaeffer WJ
    Acta Neuropathol; 2012 Mar; 123(3):419-32. PubMed ID: 22160321
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Variant ataxia-telangiectasia with prominent camptocormia.
    Paucar M; Schechtmann G; Taylor AM; Svenningsson P
    Parkinsonism Relat Disord; 2019 May; 62():253-255. PubMed ID: 30579816
    [No Abstract]   [Full Text] [Related]  

  • 99. Abdominal wall muscle fatty replacement and enlargement in autosomal dominant calpainopathy-3.
    Chompoopong P; Atwell T; Milone M
    Neuromuscul Disord; 2022 Jan; 32(1):84-85. PubMed ID: 34922801
    [No Abstract]   [Full Text] [Related]  

  • 100. A Case of a Patient with Calpainopathy Carrying Compound Heterozygous Mutations of a de novo Pathogenic Variant of c.1333G>A and a Novel Variant of c.1331C>T in CAPN3.
    Komaki S; Kubota A; Katsuse K; Kitamura A; Maeda M; Matsukawa T; Eura N; Saito Y; Nishino I; Toda T
    Intern Med; 2024 Mar; ():. PubMed ID: 38494715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.